BioSpace News Archive

Dr. Simons will lead development of custom sequencing technology for antibody screening and immune function analysis

U.S. Patent Trial and Appeal Board denies St. Regis Mohawk Tribe’s motion to terminate Restasis patent challenge.

Genoptix is the only secured creditor in all assets of Rosetta Genomics

DUR-928 is an endogenous, first-in-class small molecule, which may have broad applicability in several hepatic and renal diseases such as nonalcoholic steatohepatitis (NASH) and other disorders of the liver such as PSC, in acute organ injuries such as acute liver and kidney injury, and in inflammatory skin disorders such as psoriasis and atopic dermatitis.

New Liquid Biopsy Test Helps Physicians Select Most Effective Treatment, Prolonging Lives of Men with Metastatic Castration-resistant Prostate Cancer

Expanded Partnership Leverages Selexis’ Expertise in Recombinant Therapeutic Development Solutions

New system will include smartphone-enabled sales and distribution system connecting medicinal cannabis patients with local dispensary drivers for fast delivery and monitoring of orders.

Financing to Further Support Growth of MRIdian Linac

- New analysis from COMPASS examines the use of XARELTO® plus aspirin in reducing major adverse limb events in patients with peripheral artery disease - New CANVAS Program data assess the impact of INVOKANA® on heart failure in patients with T2D with an elevated risk of cardiovascular disease - Janssen leads in cardiovascular innovation using real-world data from wearable electrocardiogram sensors to detect asymptomatic atrial fibrillation

Five presentations of clinical and preclinical data from Magenta programs –Two presentations named among best in conference.